{
    "name": "tucatinib",
    "comment": "Rx",
    "other_names": [
        "Tukysa"
    ],
    "classes": [
        "Antineoplastics",
        "Anti-HER2",
        "Antineoplastics",
        "Tyrosine Kinase Inhibitors"
    ],
    "source": "https://reference.medscape.com/drug/tukysa-tucatinib-4000071",
    "pregnancy": {
        "common": [
            "Refer to the full prescribing information of trastuzumab and capecitabine for pregnancy and lactation information",
            "Based on animal data and its mechanism of action, fetal harm may occur when administer to pregnant females",
            "No data available on use in pregnant females to inform a drug-associated risk",
            "Verify pregnancy status of females of reproductive potential before treatment"
        ],
        "specific": [
            {
                "type": "Contraception",
                "description": [
                    "Females of reproductive potential or males with female partners of reproductive potential: Use effective contraception during treatment and at least 1 week after final dose"
                ]
            },
            {
                "type": "Infertility",
                "description": [
                    "May impair male and female fertility"
                ]
            },
            {
                "type": "Animal data",
                "description": [
                    "Administration to pregnant rats and rabbits during organogenesis resulted in embryofetal mortality, reduced fetal weight, and fetal abnormalities at maternal exposure â‰¥1.3x the AUC at the recommended dose",
                    "Advise pregnant women and females of reproductive potential of potential risk to fetus"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "No data available on the presence of tucatinib or its metabolites in human or animal milk or its effects on the breastfed child or on milk production",
            "Advise females not to breastfeed during treatment and for at least 1 week after final dose"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Severe hepatotoxicity has been report; monitor ALT, AST, and bilirubin prior to initiation, q3Weeks during treatment, and as clinically indicated",
                "May cause fetal harm",
                "Tucatinib is a substrate of CYP3A4, CYP2C8, P-glycoprotein (P-gp), and BCRP",
                "Also, reversible inhibitor of CYP3A4 and CYP2C8; time-dependent inhibitor of CYP3A4; P-gp inhibitor"
            ],
            "specific": [
                {
                    "type": "Diarrhea",
                    "description": [
                        "Severe diarrhea, including dehydration, acute kidney injury, and death, has been reported",
                        "Administer antidiarrheal treatment as clinically indicated",
                        "Perform diagnostic tests as clinically indicated to exclude other causes of diarrhea"
                    ]
                },
                {
                    "type": "Drug interaction overview",
                    "description": [
                        "Strong CYP3A or moderate CYP2C8 inducers ",
                        "Avoid coadministration",
                        "Concomitant use of tucatinib with a strong CYP3A or moderate CYP2C8 inducer decreased tucatinib plasma concentrations, which may reduce the efficacy of tucatinib",
                        "CYP2C8 inhibitors",
                        "Avoid coadministration with strong CYP2C8 inhibitors; reduce tucatinib dose if concomitant use cannot be avoided",
                        "Concomitant use of tucatinib with a strong CYP2C8 inhibitor may increase tucatinib plasma concentrations, which may increase the risk of tucatinib toxicity",
                        "Coadministration with moderate CYP2C8 inhibitors: Increase monitoring for tucatinib toxicity",
                        "CYP3A substrates",
                        "Avoid coadministration with sensitive CYP3A substrates, where minimal concentration changes may lead to serious or life-threatening toxicities",
                        "P-gp substrates",
                        "Consider reducing dose of P-gp substrates, where minimal concentration changes may lead to serious or life-threatening toxicities"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Diarrhea",
            "percent": "81"
        },
        {
            "name": "Palmoplantar erythrodysesthesia syndrome",
            "percent": "63"
        },
        {
            "name": "Decreased hemoglobin",
            "percent": "59"
        },
        {
            "name": "Nausea",
            "percent": "58"
        },
        {
            "name": "Decreased phosphate",
            "percent": "57"
        },
        {
            "name": "Increased bilirubin",
            "percent": "47"
        },
        {
            "name": "Increased ALT",
            "percent": "46"
        },
        {
            "name": "Increased AST",
            "percent": "43"
        },
        {
            "name": "Hepatotoxicity",
            "percent": "42"
        },
        {
            "name": "Decreased magnesium",
            "percent": "40"
        },
        {
            "name": "Vomiting",
            "percent": "36"
        },
        {
            "name": "Decreased potassium",
            "percent": "36"
        },
        {
            "name": "Increased creatinine",
            "percent": "33"
        },
        {
            "name": "Stomatitis",
            "percent": "32"
        },
        {
            "name": "Decreased sodium",
            "percent": "28"
        },
        {
            "name": "Increased alkaline phosphatase",
            "percent": "26"
        },
        {
            "name": "Decreased appetite",
            "percent": "25"
        },
        {
            "name": "Anemia",
            "percent": "21"
        },
        {
            "name": "Rash",
            "percent": "20"
        },
        {
            "name": "Arthralgia",
            "percent": "15"
        },
        {
            "name": "Increased creatinine",
            "percent": "14"
        },
        {
            "name": "Decreased weight",
            "percent": "13"
        },
        {
            "name": "Peripheral neuropathy",
            "percent": "13"
        },
        {
            "name": "Epistaxis",
            "percent": "12"
        },
        {
            "name": "Diarrhea",
            "percent": "64"
        },
        {
            "name": "Increased creatinine",
            "percent": "58"
        },
        {
            "name": "Increased glucose",
            "percent": "56"
        },
        {
            "name": "Decreased hemoglobin",
            "percent": "46"
        },
        {
            "name": "Increased ALT",
            "percent": "46"
        },
        {
            "name": "Fatigue",
            "percent": "44"
        },
        {
            "name": "Decreased lymphocytes",
            "percent": "39"
        },
        {
            "name": "Rash",
            "percent": "37"
        },
        {
            "name": "Nausea",
            "percent": "35"
        },
        {
            "name": "Increased AST",
            "percent": "33"
        },
        {
            "name": "Increased bilirubin",
            "percent": "28"
        },
        {
            "name": "Increased alkaline phosphatase",
            "percent": "25"
        },
        {
            "name": "Decreased albumin",
            "percent": "24"
        },
        {
            "name": "Decreased leukocytes",
            "percent": "22"
        },
        {
            "name": "Abdominal pain",
            "percent": "21"
        },
        {
            "name": "Infusion",
            "percent": "21"
        },
        {
            "name": "related reaction",
            "percent": "20"
        },
        {
            "name": "Pyrexia",
            "percent": "20"
        },
        {
            "name": "Decreased sodium",
            "percent": "19"
        },
        {
            "name": "Chills",
            "percent": "19"
        },
        {
            "name": "Decreased appetite",
            "percent": "17"
        },
        {
            "name": "Back pain",
            "percent": "16"
        },
        {
            "name": "Vomiting",
            "percent": "16"
        },
        {
            "name": "Arthralgia",
            "percent": "16"
        },
        {
            "name": "Cough",
            "percent": "16"
        },
        {
            "name": "Decreased potassium",
            "percent": "15"
        },
        {
            "name": "Decreased platelets",
            "percent": "14"
        },
        {
            "name": "Constipation",
            "percent": "14"
        },
        {
            "name": "Dyspnea",
            "percent": "13"
        },
        {
            "name": "Myalgia",
            "percent": "13"
        },
        {
            "name": "Palmoplantar erythrodysesthesia syndrome",
            "percent": "0.5-12"
        },
        {
            "name": "Diarrhea",
            "percent": "12"
        },
        {
            "name": "Decreased lymphocytes",
            "percent": "0.2-9"
        },
        {
            "name": "Hepatoxicity",
            "percent": "8"
        },
        {
            "name": "Increased ALT",
            "percent": "8"
        },
        {
            "name": "Decreased phosphate",
            "percent": "6"
        },
        {
            "name": "Increased AST",
            "percent": "6"
        },
        {
            "name": "Decreased potassium",
            "percent": "3.7"
        },
        {
            "name": "Anemia",
            "percent": "3.7"
        },
        {
            "name": "Nausea",
            "percent": "3.3"
        },
        {
            "name": "Decreased hemoglobin",
            "percent": "3"
        },
        {
            "name": "Vomiting",
            "percent": "2.5"
        },
        {
            "name": "Stomatitis",
            "percent": "2.5"
        },
        {
            "name": "Decreased sodium",
            "percent": "1.5"
        },
        {
            "name": "Increased bilirubin",
            "percent": "1"
        },
        {
            "name": "Decreased weight",
            "percent": "10"
        },
        {
            "name": "Anemia",
            "percent": "10"
        },
        {
            "name": "Anxiety",
            "percent": "7"
        },
        {
            "name": "Hypertension",
            "percent": "6"
        },
        {
            "name": "Decreased sodium",
            "percent": "3.5"
        },
        {
            "name": "Diarrhea",
            "percent": "3.5"
        },
        {
            "name": "Decreased hemoglobin",
            "percent": "2.4-3.5"
        },
        {
            "name": "Increased AST",
            "percent": "2.4-3.5"
        },
        {
            "name": "Increased bilirubin",
            "percent": "2.4"
        },
        {
            "name": "Increased glucose",
            "percent": "2.4"
        },
        {
            "name": "Increased ALT",
            "percent": "2.3"
        },
        {
            "name": "Abdominal pain",
            "percent": "2.3"
        },
        {
            "name": "Fatigue",
            "percent": "2.3"
        },
        {
            "name": "Back pain",
            "percent": "1.2"
        },
        {
            "name": "Constipation",
            "percent": "1.2"
        },
        {
            "name": "Chills",
            "percent": "1.2"
        },
        {
            "name": "Arthralgia",
            "percent": "1.2"
        },
        {
            "name": "Increased alkaline phosphatase",
            "percent": "1.2"
        },
        {
            "name": "Decreased bilirubin",
            "percent": "1.2"
        },
        {
            "name": "Decreased potassium",
            "percent": "0.8"
        },
        {
            "name": "Decreased magnesium",
            "percent": "0.7"
        },
        {
            "name": "Rash",
            "percent": "0.5"
        },
        {
            "name": "Arthralgia",
            "percent": "0.5"
        },
        {
            "name": "Peripheral neuropathy",
            "percent": "0.5"
        },
        {
            "name": "Increased alkaline phosphatase",
            "percent": "0.5"
        },
        {
            "name": "Decreased appetite",
            "percent": null
        }
    ]
}